Reboxetine for Central Pain: A Single-Blind Prospective Study

Publisher Website

1 July 2002

journal article
research article
Published by Wolters Kluwer Health in Clinical Neuropharmacology

Vol. 25 (4), 238-239
https://doi.org/10.1097/00002826-200207000-00009

Abstract

No abstract available

Keywords

PROSPECTIVE STUDY

This publication has 5 references indexed in Scilit:

Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons
European Journal of Neuroscience, 2001
Reboxetine: the first selective noradrenaline re-uptake inhibitor
Expert Opinion on Pharmacotherapy, 2000
The neurochemistry of central pain: evidence from clinical studies, hypothesis and therapeutic implications
Pain, 1998
Effects of Desipramine, Amitriptyline, and Fluoxetine on Pain in Diabetic Neuropathy
New England Journal of Medicine, 1992
ROLE OF SPINAL NORADRENERGIC SYSTEM IN TRANSMISSION OF PAIN IN PATIENTS WITH SPINAL CORD INJURY
The Lancet, 1986

Cited by 13 articles